Insulin Pen Needles Market | Contrive Datum Insights

The global Insulin Pen Needles market is projected to grow at a CAGR of 8.1% during the forecast period.

Insulin Pen Needles Market Overview:

Insulin pens are becoming more and more popular as diabetics now prefer to use insulin pens to inject insulin. Insulin pens contain a disposable needle disk for measuring doses and a cartridge. They allow for simpler, more convenient, and more accurate delivery than using syringes and vials. The rising prevalence of diabetes, continuous advancements in insulin pens by key players, growing demand for safe vaccinations, rising preference for apps for home use, favorable reimbursement scenarios in developed countries, and awareness about insulin pens are Several factors that are expected to increase the market growth over the forecast period. For example, in September 2019, Owen Mumford Inc. announced the launch of Asteria SafeControl, the next generation of safety pen needles.

Insulin Pen Needles market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Insulin Pen Needles market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• In September 2019, Owen Mumford Inc. announced the launch of Asteria SafeControl, the next generation of safety pen needles.
• In January 2019, BD received FDA clearance for its second-generation BD Nanopen needle, designed for more reliable subcutaneous injection depth.
• In May 2018, Hindustan Syringes & Medical Devices (HMD) launched India's first 'Dispovan Insulin Pen Needle' for better comfort for diabetic patients.

Major Segments Covered in the Global Insulin Pen Needles Market:

Market Key Players:
BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa, Beipu, Kangdelai, Ulticare, Allison Medical, Dongbao, And Others.

Insulin Pen Needles Market by Types:

• Standard Insulin Pen Needles
• Safety Insulin Pen Needles

Insulin Pen Needles Market by Applications:

• Type I Diabetes
• Type II Diabetes

• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Insulin Pen Needles Market by Regions:

The report estimates revenue growth at the worldwide, regional, and country levels and delivers an analysis of the recent industry trends in each sub-segment from 2017 to 2030.

The global insulin pen needles market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to lead the global insulin pen needles market owing to rising prevalence of diabetes in the region. In 2020, 34.2 million Americans had diabetes, according to the National Diabetes Statistics Report. Furthermore, the availability of favorable reimbursement schemes and increasing R&D investments in insulin pens are responsible for its dominance. The market in Europe is likely to witness substantial growth throughout the forecast period owing to the increasing geriatric population and rising prevalence of diabetes. The rising number of diabetic patients, rising preference for home-use apps and safe vaccinations, and awareness about insulin pen needles are the factors driving the growth of the Asia Pacific and Latin America markets during the forecast period. On the other hand, the insulin pen needles market in Middle East & Africa is expected to witness lucrative growth in the near future owing to continuous advancements in insulin pen technology.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Report Scope of Global Insulin Pen Needles Market:

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the Market such as Market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years of data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, region, type, application and etc., and custom research can be added according to specific requirements.
• The report contains a SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Frequently Asked Questions-

What are the key types and applications of the Insulin Pen Needles market?

- Standard Insulin Pen Needles, Safety Insulin Pen Needles

- Type I Diabetes, Type II Diabetes

Who are the key players in the Insulin Pen Needles market?

BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa, Beipu, Kangdelai, Ulticare, Allison Medical, Dongbao, And others.

Any special requirements about this report, please let us know and we can provide a custom report.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19 and the Russia-Ukraine war.